Chargement en cours...
FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner
Glioma is the most common brain tumor with a dismal prognosis. While temozolomide (TMZ) based chemotherapy significantly improves survival in glioma patients, resistance against this compound commonly leads to glioma treatment failure. Overexpression of long-noncoding RNA (LncRNA) FoxD2 adjacent opp...
Enregistré dans:
| Publié dans: | Korean J Physiol Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Physiological Society and The Korean Society of Pharmacology
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819902/ https://ncbi.nlm.nih.gov/pubmed/31680769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2019.23.6.475 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|